Breast Cancer Clinical Trial

Promoting Informed Choice for Breast Cancer Screening

Summary

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

View Full Description

Full Description

In this study, the goal is to identify the prevalence and predictors of reactance, self-exemption, disbelief, and source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust. Research has not yet systematically identified the proportion of women who respond negatively (vs. positively) to evidence about the benefits and harms of mammography screening, or attempted to explain these responses by examining theory-driven predictors. The Investigator will develop and conduct a probability-based nationally representative survey in which mammography evidence is communicated using current best practices in risk communication. The Investigators will identify theory-driven predictors of negative and positive responses to that evidence, and identify consequences of these responses for screening decision-making and trust.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Female
Between 39-49 years of age
No history of breast cancer
No known BRCA 1/2 mutation

Exclusion Criteria:

Non-English or Spanish Speaking
Persons unable to provide informed consent (e.g. sever dementia or cognitive disability or illiterate
History of breast cancer
Known BRCA 1/2 mutation

Study is for people with:

Breast Cancer

Estimated Enrollment:

498

Study ID:

NCT05376241

Recruitment Status:

Active, not recruiting

Sponsor:

University of Colorado, Denver

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Colorado Hospital
Aurora Colorado, 80045, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

498

Study ID:

NCT05376241

Recruitment Status:

Active, not recruiting

Sponsor:


University of Colorado, Denver

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.